Japan approves ENHERTU for treatment of adult patients with HER2 positive unresectable breast cancer
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Monetary awards worth Rs 1.20 crore were presented amongst the winners for their remarkable contributions
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
The companies will leverage their respective proprietary technology platforms
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Subscribe To Our Newsletter & Stay Updated